|
Originally published In Press as doi:10.1074/jbc.M201625200 on April 8, 2002
J. Biol. Chem., Vol. 277, Issue 24, 21598-21603, June 14, 2002
Conclusive Evidence That the Major T-cell Antigens of the
Mycobacterium tuberculosis Complex ESAT-6 and CFP-10
Form a Tight, 1:1 Complex and Characterization of the Structural
Properties of ESAT-6, CFP-10, and the ESAT-6·CFP-10
Complex
IMPLICATIONS FOR PATHOGENESIS AND VIRULENCE*
Philip S.
Renshaw ,
Parthena
Panagiotidou§,
Adam
Whelan¶,
Stephen V.
Gordon¶,
R. Glyn
Hewinson¶,
Richard A.
Williamson§, and
Mark D.
Carr
From the Department of Biochemistry, University of
Leicester, Adrian Building, University Road, Leicester LE1 7RH,
§ Department of Biosciences, University of Kent, Canterbury,
Kent CT2 7NJ, and ¶ TB Research Group, Department of Bacterial
Diseases, Veterinary Laboratories Agency Weybridge, New Haw,
Addlestone, Surrey KT15 3NB, United Kingdom
Received for publication, February 18, 2002, and in revised form, April 4, 2002
 |
ABSTRACT |
The proteins ESAT-6 and CFP-10 have been shown to
be secreted by Mycobacterium tuberculosis and
Mycobacterium bovis cells, to be potent T-cell antigens,
and to have a clear but as yet undefined role in tuberculosis
pathogenesis. We have successfully overexpressed both ESAT-6 and CFP-10
in Escherichia coli and developed efficient purification
schemes. Under in vivo-like conditions, a combination of
fluorescence, circular dichroism, and nuclear magnetic resonance spectroscopy have shown that ESAT-6 contains up to 75% helical secondary structure, but little if any stable tertiary structure, and
exists in a molten globule-like state. In contrast, CFP-10 was found to
form an unstructured, random coil polypeptide. An exciting discovery
was that ESAT-6 and CFP-10 form a tight, 1:1 complex, in which both
proteins adopt a fully folded structure, with about two-thirds of the
backbone in a regular helical conformation. This clearly suggests that
ESAT-6 and CFP-10 are active as the complex and raises the interesting
question of whether other ESAT-6/CFP-10 family proteins (22 paired
genes in M. tuberculosis) also form tight, 1:1 complexes,
and if so, is this limited to their genome partner, or is there scope
for wider interactions within the protein family, which could provide
greater functional flexibility?
 |
INTRODUCTION |
Tuberculosis is one of the oldest infectious diseases known to
mankind (1, 2) and remains one of the most significant bacterial
diseases of humans, with about one-third of the world's population
infected resulting in ~3 million deaths annually (3-6). The bacteria
responsible for tuberculosis belong to the Mycobacterium tuberculosis complex, which is a group of highly related
mycobacteria. The complex includes M. tuberculosis, which is
responsible for the majority of human tuberculosis, and
Mycobacterium bovis, which causes tuberculosis in a range of
domesticated and wild animals. The complete sequence of the M. tuberculosis genome was reported about 3 years ago (7) and is
believed to contain genes for 3,959 proteins (8, 9). However, we still
have relatively little information about which proteins are essential
for pathogenesis and even less knowledge of their structures,
functions, and mechanisms of action.
The only currently effective vaccine for tuberculosis is a live
attenuated strain of M. bovis known as Bacille
Calmette-Guérin (BCG);1
however, despite being one of the most widely used vaccines in the
world the molecular basis for the attenuation of M. bovis BCG remains unclear. Recently, genomic hybridization techniques have
identified a number of deletions in the genomes of BCG daughter strains; however, only one of these, termed RD1, is deleted
consistently from BCG strains but present in all virulent isolates of
M. bovis and M. tuberculosis (10, 11). The RD1
deletion contains the genes for nine proteins (Rv3871-Rv3879c), which
are clearly implicated in pathogenesis. The genes Rv3874 and Rv3875
code for two sequence-related (25% homology) proteins known as CFP-10
(100 residues) and ESAT-6 (95 residues), respectively. Expression of
these two genes has been shown to be coordinately regulated, and both
ESAT-6 and CFP-10 are found at low levels in M. tuberculosis
and M. bovis culture supernatants (12). In addition, the two
proteins are potent T-cell antigens recognized by over 70% of
tuberculosis patients (13), which has led to their proposed use as
diagnostic reagents for tuberculosis in both humans and animals (14,
15). Preliminary data from a dual knockout of ESAT-6 and CFP-10 in
M. bovis appears to indicate that the loss of at least one
of these genes results in a significant reduction in the virulence of
the engineered M. bovis, which further emphasizes the
potential importance of both proteins in tuberculosis pathogenesis and
virulence (16). Neither CFP-10 nor ESAT-6 shows any significant
sequence similarity with any proteins of known tertiary structure or
function. However, they are both members of a large family of
mycobacterial proteins found in the M. tuberculosis complex
(12, 17), which, in common with CFP-10 and ESAT-6, are found in pairs
within the genome, often preceded by members of the PE and PPE
gene family (7, 12, 17).
We have produced successfully both CFP-10 and ESAT-6 in
Escherichia coli, and in this communication we report the
results of detailed structural characterization of both proteins using a combination of fluorescence, circular dichroism, and nuclear magnetic
resonance (NMR) spectroscopy.
 |
EXPERIMENTAL PROCEDURES |
Protein Expression Vectors--
A pET21a-based expression vector
containing the full coding sequence for ESAT-6 was generated by a
PCR-based approach and maintained in E. coli BL21(DE3)
cells. The ESAT-6 coding sequence was amplified from M. bovis AN5 DNA using appropriate primers and cloned into the
NdeI and SalI sites of pET21a. The CFP-10 and
CFP-10/ESAT-6 expression vectors were produced similarly by a PCR-based
approach, with an artificial bacterial chromosome (Rv414; see Ref. 18)
containing the full coding regions for both CFP-10 and ESAT-6 used as a
template. The PCR primers used to amplify the CFP-10 coding region were
designed to include NcoI and BamH1 restriction
sites to allow insertion into pET28a. The larger PCR product containing
the coding region for both CFP-10 and ESAT-6 included an
NdeI site in place of the NcoI site and was
designed to allow the expression of an N-terminal,
His6-tagged variant of CFP-10 following ligation
into pET28a. After construction, the integrity of both expression
vectors was confirmed by DNA sequencing.
Expression and Purification of ESAT-6--
E. coli
BL21(DE3) transformed with the pET21a-based expression vector for
ESAT-6 were grown in LB medium containing 100 µg/ml ampicillin. The expression of ESAT-6 was induced in mid-log phase (corresponding to an absorbance at 600 nm of 0.6-0.7) by the addition of isopropyl-1-thio- -D-galactopyranoside to 0.45 mM, and the cells were then harvested after 4 h by
centrifugation at 7800 × g for 15 min (4 °C). The
cell pellets obtained were resuspended and lysed with Bugbuster HT
(Novagen) to which was added 0.5 mM EDTA and 100 µM phenylmethylsulfonyl fluoride to inhibit protease activity. The insoluble fraction of the cell lysate, containing the
ESAT-6 as inclusion bodies, was recovered by centrifugation (12100 × g for 15 min at 4 °C), and the inclusion bodies were then washed three times in a 50 mM Tris, 10 mM
EDTA, and 0.5% (v/v) Triton X-100 buffer adjusted to pH 8.0. After the
final wash, the ESAT-6 inclusion bodies were solubilized in 6 M guanidine hydrochloride containing 1 mM EDTA
and 100 µM phenylmethylsulfonyl fluoride to give a final
ESAT-6 concentration of 0.5 to 1 mg/ml. This solution was dialyzed
initially against a 25 mM NaH2PO4, 100 mM NaCl, and 1 mM EDTA refolding buffer at
pH 6.5 and then into the Q-Sepharose column running buffer consisting
of 20 mM Bis-Tris and 1 mM EDTA at pH 6.5. The
final purification of ESAT-6 was carried out using a 20-ml Q-Sepharose
column to which was applied a stepwise gradient of increasing NaCl
concentration. The ESAT-6 was eluted at 150 mM NaCl and was
judged to be greater than 95% pure by SDS-PAGE (Invitrogen 4-12%
Bis-Tris NuPAGE gel system) and electrospray mass spectrometry.
Expression and Purification of CFP-10--
E. coli
cells transformed with the pET28a-based expression vector for CFP-10
were grown in LB medium containing 40 µg/ml kanamycin and were
harvested 4 h after induction by
isopropyl-1-thio- -D-galactopyranoside in mid-log phase.
The cell pellets were lysed with Bugbuster HT, as described previously,
and the soluble fraction containing CFP-10 was then dialyzed into a 20 mM Tris and 1 mM EDTA column running buffer at
pH 8.0. Initial purification of CFP-10 was carried out on a 20-ml
Q-Sepharose column pre-equilibrated with the pH 8.0 Tris buffer. The
column was washed with a stepwise gradient of increasing NaCl
concentration and CFP-10 eluted in the 50 to 75 mM NaCl
washes. Fractions containing CFP-10 were pooled, dialyzed against a 20 mM piperazine and 1 mM EDTA buffer at pH 5.8, and then applied to a 20-ml Q-Sepharose column pre-equilibrated with the same piperazine buffer. CFP-10 was eluted from this column in a 50 mM NaCl wash and was judged to be over 95% pure.
Expression and Purification of His-tagged CFP-10--
E.
coli cells transformed with the expression vector for
hexa-His-tagged CFP-10 were grown in LB medium containing 40 µg/ml kanamycin and were harvested 4 h after induction with
isopropyl-1-thio- -D-galactopyranoside. The cells were
lysed with Bugbuster HT, and the soluble fraction containing His-tagged
CFP-10 was then dialyzed into a 20 mM Tris, 100 mM NaCl, and 1 mM EDTA buffer at pH 8.0. The
protein was purified by using a 10-ml Ni-NTA column pre-equilibrated
with the pH 8.0 buffer, which was washed with a stepwise gradient of
increasing imidazole concentration. The His-tagged CFP-10 was eluted in
the 50 mM imidazole wash and was found to be at least 95%
pure. It should be noted that if His-tagged CFP-10 was prepared from
cells grown in medium containing only 20 µg/ml kanamycin then the
purified protein was found to contain roughly equal amounts of both
His-tagged CFP-10 and ESAT-6.
Circular Dichroism Spectroscopy--
The far UV CD
spectra used to determine the secondary structure of ESAT-6, CFP-10,
and the ESAT-6·CFP-10 complex were acquired on a Jasco 715 spectrometer. The spectra were collected from protein samples dissolved
in a 25 mM NaH2PO4 and 100 mM NaCl buffer at pH 6.5, with the protein concentration
adjusted to give an absorbance at 280 nm of about 1.0 for a path length
of 1 cm. Typically, spectra were recorded from 180 to 250 nm at a scan
speed of 20 nm per min, with each spectrum representing the average of
10 accumulations. During acquisition the samples were maintained at a
regulated temperature (15 to 40 °C) in a 0.1-mm path length cell.
Fluorescence Spectroscopy--
Intrinsic fluorescence spectra of
protein samples were acquired on a PerkinElmer Life Sciences
LS50B luminescence spectrometer. The spectra were recorded at 20 °C
with excitation at 280 nm and fluorescence monitored from 300 to 450 nm. The final spectra were the average of 10 accumulations collected at
a scan rate of 150 nm per min. Typically, the spectra were acquired
from 1 µM protein samples dissolved in a 25 mM NaH2PO4 and 100 mM
NaCl buffer at pH 6.5.
NMR Spectroscopy--
The one-dimensional and 2D 1H
NMR experiments were carried out on 350 µl samples of 0.5 to 1.0 mM ESAT-6, CFP-10, and ESAT-6·CFP-10 complex dissolved in
a 25 mM NaH2PO4 and 100 mM NaCl buffer at pH 6.5 (10% D2O). NMR data
were acquired on 600-MHz Varian Inova and Bruker Avance spectrometers
at temperatures between 15 and 35 °C. The 2D nuclear Overhauser
effect spectroscopy (19) and total correlation spectroscopy (20)
spectra were recorded with mixing times of 100-150 and 45 ms,
respectively, with typical acquisition times of 35 ms in F1
and 250 ms in F2.
Fluorescence-based Binding Assays--
Intrinsic fluorescence
spectra were collected as described above for a series of samples
containing 1 µM CFP-10 and increasing concentrations of
ESAT-6 (0 to 2.25 µM). The protein samples were prepared
in a 25 mM NaH2PO4 and 100 mM NaCl buffer at pH 6.5 and were incubated for 3 h at
room temperature before acquiring the fluorescence spectra.
Pull Down Binding Assays--
In a typical pull down binding
assay 0.1 µmol of His-tagged CFP-10 was loaded initially onto a 10-ml
Ni-NTA column in a 20 mM Tris, 100 mM NaCl, and
1 mM EDTA buffer at pH 8.0, and the column was washed with
five column volumes of the buffer. A slight molar excess of ESAT-6 was
then applied to the column, and any protein that failed to bind was
removed by washing once more with five column volumes of the Tris
buffer including 20 mM imidazole. The proteins bound to the
column were finally eluted in a 20 mM Tris and 100 mM NaCl buffer at pH 8.0 containing 100 mM
imidazole, and the composition of the protein fractions was analyzed by
SDS-PAGE.
Protein Denaturation Analysis--
The conformational stability
of ESAT-6, CFP-10, and the ESAT-6·CFP-10 complex to denaturation by
guanidine hydrochloride was determined by monitoring the change in the
wavelength of maximum intrinsic fluorescence emission as a function of
guanidine hydrochloride concentration (21). The experiments were
carried out on 0.5 to 1.5 µM samples of the proteins
dissolved in a 25 mM NaH2PO4 and
100 mM NaCl buffer at pH 6.5, which contained between 0 and 2.25 M guanidine hydrochloride. The proteins were incubated
with the denaturant overnight at 4 °C and then intrinsic
fluorescence spectra were acquired at 10 °C as described previously.
Calculation of Protein Dendrogram--
The neighbor-joining
phylogenetic tree for the ESAT-6/CFP-10 family of proteins was
calculated using the ClustalX package (22), with the M. tuberculosis and Mycobacterium leprae sequences of CFP-10/ESAT-6 family proteins obtained from the TuberculList and
Leproma servers at the Pasteur Institute
(www.genolist.pasteur.fr/TuberculList and
www.genolist.pasteur.fr/ Leproma).
 |
RESULTS |
Protein Expression and Purification--
The expression of ESAT-6
in E. coli resulted in the production of insoluble inclusion
bodies of the protein, which were isolated and solubilized in guanidine
hydrochloride, and the ESAT-6 was refolded by removal of the denaturant
by dialysis. Prior to purification on a Q-Sepharose column the refolded
ESAT-6 was found typically to contain three main protein components,
which were shown by electrospray mass spectrometry to have masses of
9902.8 ± 1.1 (~75%), 9772.2 ± 1.1 (~20%), and
8807.6 ± 0.9 Da (~5%). The mass values obtained correspond to
those expected for full-length ESAT-6 (9903.9 Da), ESAT-6 minus the
N-terminal methionine (9772.7 Da), and ESAT-6 with the last 11 C-terminal residues removed (8807.6 Da). If phenylmethylsulfonyl
fluoride and EDTA were omitted from the refolding buffers then the
majority of the refolded ESAT-6 obtained was present as the
C-terminally truncated species, which clearly arises from proteolytic
cleavage between Ala-84 and Ser-85. The full-length ESAT-6 and ESAT-6
minus the N-terminal methionine were separated from the C-terminally
truncated form by chromatography on Q-Sepharose and once purified were
stable for many days at 20 °C. Typical yields for purified ESAT-6
were about 40 mg/liter.
In contrast to ESAT-6, CFP-10 was expressed in E. coli as a
soluble product, and the mass determined for the purified protein (10662.2 ± 0.6 Da) corresponds to that expected for CFP-10 after removal of the N-terminal methionine (10662.6 Da). Typical yields of
purified CFP-10 were about 20 mg/liter. The His-tagged CFP-10 was also
expressed as a soluble protein, and yields of about 10 mg/liter were
obtained after purification. The E. coli cells transformed with the dual His-tagged CFP-10/ESAT-6 expression vector were grown
initially in the presence of 40 µg/ml kanamycin and under these
conditions showed no detectable coexpression of ESAT-6 with His-tagged
CFP-10; however, when this was reduced to 20 µg/ml both proteins were
detected by SDS-PAGE in roughly equal quantities. In addition, SDS-PAGE
analysis of the protein isolated by Ni-NTA affinity chromatography of
the lysate from cells grown at the lower kanamycin concentration
revealed that the bound material consisted of an equimolar mixture of
His-tagged CFP-10 and ESAT-6, which suggested that the proteins formed
a stable, 1:1 complex.
Structural Characterization of the Proteins--
Typical intrinsic
fluorescence spectra obtained for ESAT-6 (Trp-6, Trp-43, and Trp-58),
CFP-10 (Trp-43), and the ESAT-6·CFP-10 complex are shown in Fig.
1. The spectra of both ESAT-6 and CFP-10 are characterized by a fluorescence maximum at about 353 nm at 20 °C, which corresponds to that expected for proteins in which all
the tryptophan residues are fully exposed to the aqueous solvent. In
contrast, the fluorescence maximum observed for the ESAT-6·CFP-10 complex is blue-shifted to around 342 nm, which indicates that at least
one of the four tryptophan side chains has moved to a significantly
less polar environment on complex formation, such as the hydrophobic
core of the complex.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
Intrinsic fluorescence emission spectra
obtained for CFP-10 (A), ESAT-6 (B),
and the 1:1 ESAT-6·CFP-10 complex (C) at
20 °C. The wavelengths of maximum emission are 353, 353, and
342 nm, respectively, which indicates that the tryptophan residues are
fully exposed to the aqueous solvent in both ESAT-6 and CFP-10 but that
one or more of the tryptophans become partially or fully buried on
formation of the complex.
|
|
The far UV circular dichroism spectra shown in Fig
2 are representative of those acquired
for ESAT-6, CFP-10, and the ESAT-6·CFP-10 complex. The spectra
obtained for both ESAT-6 and the ESAT-6·CFP-10 complex are typical of
those seen for proteins with a high helical content, whereas the
strikingly different spectrum observed for CFP-10 alone is indicative
are a largely unstructured, random coil polypeptide (23, 24). Analysis
of these spectra with the CDPro package (25) provided estimates of the
secondary structure content for ESAT-6 (56% helix, 7% sheet, 12%
turns, and 25% unstructured), CFP-10 (13% helix, 19% sheet, 17%
turns, and 51% unstructured), and the complex (66% helix, 4% sheet,
9% turns, and 21% unstructured).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Far UV circular dichroism spectra acquired
from solutions of CFP-10 (A), ESAT-6
(B), and the 1:1 ESAT-6·CFP-10 complex
(C) at 25 °C. Clearly both ESAT-6 and the
ESAT-6·CFP-10 complex have a high helical content, whereas CFP-10
appears to have relatively little regular secondary structure.
|
|
Fig. 3 shows the one-dimensional
1H NMR spectra recorded for ESAT-6, CFP-10, and the
ESAT-6·CFP-10 complex. The spectrum observed for the complex contains
all the features expected for a folded protein, such as the cluster of
high field-shifted methyl signals between 0 and 0.6 ppm and a
significant number of resonances from backbone amide groups between 8.5 and 9.5 ppm. In addition, the line widths of the 1H signals
indicate that the complex is a simple ESAT-6·CFP-10 heterodimer with
a combined molecular mass of 20.5 kDa. The spectrum of the
complex contrasts sharply with that obtained for CFP-10, in which there
is no evidence of signals shifted from their random coil chemical
shifts and therefore no evidence of any significant folded structure
(26). The spectrum obtained for ESAT-6 clearly sits somewhere between
that of the complex and CFP-10, with a few 1H signals
clearly shifted from random coil values, such as those from backbone
NH groups between 8.5 and 9.3 ppm. Another noticeable feature of
the ESAT-6 spectrum is that the 1H resonances are very
broad compared with those of the ESAT-6·CFP-10 complex. This is the
opposite of what is expected as the line width of signals from ESAT-6
(9.9 kDa) should be about half of those for the complex (20.5 kDa)
because of the 2-fold difference in molecular mass. The broad
1H signals observed for ESAT-6 are indicative of either
protein aggregation or exchange between multiple conformations. In 2D total correlation spectroscopy spectra of ESAT-6 collected under the
same conditions at least 15 weak cross-peaks were detected between
signals from backbone amide groups, which can only arise as a result of
interconversion between multiple conformations in some regions of
ESAT-6 (27). In addition, analysis of the 2D nuclear Overhauser effect
spectroscopy and total correlation spectroscopy spectra of ESAT-6
suggests that over 70% of the signals from backbone NH groups may be
broadened significantly by the exchange between multiple conformations,
to the extent that cross-peaks involving these signals are not observed
in 2D total correlation spectroscopy spectra.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
One-dimensional 1H NMR spectra
recorded for CFP-10 (A), ESAT-6 (B), and the
ESAT-6·CFP-10 complex (C). The contrasting broad
signals for ESAT-6 and sharp signals for CFP-10 reflect the respective
molten globule and random coil states of the two proteins. The spectrum
for the complex shows significant dispersion of signals from backbone
amide groups (6.5 to 9.5 ppm) and a number of high field-shifted methyl
resonances (0 to 0.6 ppm), which are both characteristic features of a
folded protein.
|
|
The graph shown in Fig. 4 illustrates the
effect of increasing guanidine hydrochloride concentration on the
wavelength of maximum intrinsic tryptophan fluorescence observed for
ESAT-6, CFP-10, and the ESAT-6·CFP-10 complex. The data show clearly
that the ESAT-6·CFP-10 complex is stable up to about 0.5 M guanidine hydrochloride and then undergoes a cooperative
unfolding reaction with a midpoint at 0.9 M guanidine
hydrochloride, which is the type of behavior expected for a folded
protein (21) and suggests that protein dissociation and unfolding occur
as a single event. In contrast, ESAT-6 does not show a cooperative
denaturation curve, which suggests that the protein lacks any stable
tertiary structure under native conditions. In the case of CFP-10, the
wavelength of maximum fluorescence in the absence of guanidine
hydrochloride already corresponds to that expected for a tryptophan
fully exposed to an aqueous environment and is therefore insensitive to
any unfolding induced by the denaturant.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Typical guanidine hydrochloride-induced
denaturation curves for ESAT-6 ( ), CFP-10 ( ), and the
ESAT-6·CFP-10 complex ( ). Denaturation of the proteins was
followed by monitoring the change in the wavelength of maximum
intrinsic fluorescence as a function of increasing denaturant
concentration.
|
|
Secondary structure predictions were obtained for both ESAT-6 and
CFP-10 using the JPRED2 package (28). ESAT-6 is predicted to consist of
three helical regions (residues 3 to 18, 23 to 42, and 50 to 86) linked
by short loops with an overall helical content of 77%. This is a
somewhat higher helical content than the 56% obtained from analysis of
CD spectra acquired at 25 °C but very close to the 75% helix
indicated by CD spectra recorded at 15 °C. CFP-10 is also predicted
to contain only helical secondary structure with five helices (residues
3 to 15, 18 to 22, 29 to 35, 44 to 78, and 87 to 96) joined by short
loops, which corresponds to an overall helical content of 70%. This
figure contrasts sharply with the predominantly random coil structure
indicated for CFP-10 by the CD and NMR analysis.
ESAT-6·CFP-10 Complex Formation--
Fig.
5 illustrates the effect of increasing
the molar ratio of ESAT-6 to CFP-10 on the wavelength of maximum
intrinsic fluorescence observed for the mixture. The fluorescence
maximum initially shifts from about 353 to 342.5 nm, with the shortest
wavelength attained at a molar ratio of 1.0, and then shows a steady
increase. The data strongly suggest that the two proteins interact to
form a tight, 1:1 complex, in which the environment of at least
one of the four tryptophan residues is significantly less polar and is therefore consistent with increased folding of one or both
proteins.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 5.
A typical example of the change in the
wavelength of maximum intrinsic fluorescence observed on increasing the
molar ratio of ESAT-6 to CFP-10, which clearly suggests that the two
proteins form a tight, 1:1 complex.
|
|
The results of SDS-PAGE analysis of a typical ESAT-6 pull down assay
using His-tagged CFP-10 bound to a Ni-NTA column as the bait are shown
in Fig. 6. ESAT-6 was shown previously
not to bind to the Ni-NTA column, and so the data clearly indicate that
ESAT-6 binds tightly to His-tagged CFP-10. In addition, the staining intensity observed for the two components of the ESAT-6·CFP-10 complex clearly suggests a stoichiometry of 1:1.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 6.
SDS-PAGE analysis of a typical ESAT-6 pull
down assay using His-tagged CFP-10 bound to a Ni-NTA affinity column as
bait. Lane 3 corresponds to 128 pmol of the bound protein
eluted from the column by imidazole after initially loading 100 nmol of
His-tagged CFP-10 followed by an excess of ESAT-6. For comparison
lanes 2 and 4 contain 128 pmol of ESAT-6 and
CFP-10, respectively. Lane 1 corresponds to a range of low
molecular mass marker proteins (Sigma). The data clearly suggest
that ESAT-6 and CFP-10 form a tight, 1:1 complex.
|
|
 |
DISCUSSION |
SDS-PAGE analysis of ESAT-6 purified from short term culture
filtrates of M. tuberculosis has shown that the secreted
protein consists of two major species, which both have the predicted N terminus and run with apparent molecular masses of between 4 and 6 kDa
(29). This behavior is very similar to that observed for E. coli-expressed ESAT-6, where mass spectrometry revealed that the
higher molecular mass band corresponds to a mixture of
full-length ESAT-6 and ESAT-6 minus the N-terminal methionine and that
the lower molecular weight species corresponds to ESAT-6 with 11 C-terminal residues removed. The similarity suggests that naturally
secreted ESAT-6 is also highly susceptible to proteolytic removal of
the 11 C-terminal residues.
The circular dichroism spectra recorded for ESAT-6 indicate clearly
that the majority of the protein is in a helical conformation at
temperatures below 20 °C, with quantitative analysis of the data
suggesting a helical content of about 75%, which is very close to the
77% suggested by secondary structure predictions. The helical
structure though is relatively unstable and falls to around 56% at
25 °C and less than 30% at 40 °C. In addition, ESAT-6 shows no
resistance to denaturation by guanidine hydrochloride, which suggests
that the protein is not folded fully even in the absence of the
denaturant. The 1H NMR data acquired for ESAT-6 clearly
indicate that a significant proportion of the protein (possibly as high
as 70%) exists in multiple conformations, which interconvert on a time
scale that leads to significant broadening of the 1H NMR
signals from ESAT-6 and provides further evidence of structural instability in ESAT-6. Taken together, the spectroscopic data and
structural predictions suggest that under in vivo-like
conditions ESAT-6 contains a number of regions of regular helical
secondary structure but little if any stable tertiary structure, and so the structure of isolated ESAT-6 appears to resemble a molten globule-like state.
In contrast to ESAT-6, the combined features of the circular dichroism,
fluorescence, and 1H NMR spectra of CFP-10 indicate clearly
that the protein is an essentially unstructured, random coil
polypeptide under in vivo-like conditions. This is somewhat
surprising given a predicted helical content of over 70% and also the
significant sequence similarity between CFP-10 and ESAT-6 (about 25% homology).
The changes observed in the wavelength of maximum intrinsic
tryptophan fluorescence on titrating CFP-10 with ESAT-6, together with
the results of ESAT-6 pull down assays using His-tagged CFP-10, indicate clearly that ESAT-6 and CFP-10 form a tight, 1:1 complex. The
fluorescence measurements were carried out at a CFP-10 concentration of
1 µM, and the distinct minimum in the wavelength of
maximum intrinsic tryptophan fluorescence at an ESAT-6:CFP-10 ratio of 1:1 (Fig. 5) indicates not only that the two proteins form a 1:1 complex but also that at least 90% of the ESAT-6 and CFP-10 are bound
together at a concentration of 1 µM, which means that the binding is tight with a dissociation constant for the complex of
1.1 × 10 8 M or lower.
The spectroscopic and chemical denaturation data obtained for the
ESAT-6·CFP-10 complex show clearly that both proteins adopt a stable,
fully folded structure in the complex. In recent years it has become
clear that this type of behavior, in which a protein or protein domain
is only folded fully when bound to its target or partner molecule, is
more common than expected initially and may confer a number of
functional advantages, including tighter control of the activity of
regulatory proteins such as transcription factors and a general
mechanism for increasing the specificity of protein-protein and
protein-nucleic acid interactions (30, 31). Analysis of the circular
dichroism spectra obtained for the ESAT-6·CFP-10 complex suggests
that about two-thirds of the polypeptide backbone adopts a regular
helical conformation, which is only slightly lower than the helical
content expected from secondary structure predictions determined for
ESAT-6 and CFP-10. The large number of NH to NH nuclear Overhauser
effects seen in 2D nuclear Overhauser effect spectroscopy spectra of
the complex also indicates a predominantly helical secondary structure
(26) and is entirely consistent with the circular dichroism data.
The adjacent genes for CFP-10 (Rv3874) and ESAT-6 (Rv3875) are
cotranscribed and despite lacking a recognizable secretory signal
sequence are both found in significant quantities in short term culture
filtrates of M. tuberculosis (12, 29). In addition, the work
reported here shows clearly that ESAT-6 and CFP-10 only adopt a stable,
fully folded structure when they form a tight, 1:1 complex. The
expression characteristics of both proteins, together with their
structural properties, clearly suggest that the biologically active
form of ESAT-6 and CFP-10 will be as the complex.
CFP-10 and ESAT-6 are members of a large family of proteins found in
the M. tuberculosis complex, which, in common with CFP-10 and ESAT-6, are generally found in pairs within the genome (7, 12, 17,
32). The phylogenetic tree calculated for the ESAT-6/CFP-10 family
proteins identified in the M. tuberculosis (11 pairs) and M. leprae genomes (four pairs and two single genes; see
Refs. 7 and 9) reveals that the proteins fall mainly into one of three
pairing groups (Fig. 7). Interestingly,
only the ESAT-6 and CFP-10 genes are conserved individually in M. leprae (ML0049 and ML0050, respectively), whereas the M. leprae proteins coded by ML2531/ML2532 seem to substitute for both
the Rv0287/Rv0288 and Rv3019c/Rv3020c pairs from M. tuberculosis, and another single pair of M. leprae
proteins (ML1055/1181 and ML1056/1180) appears to substitute for five
pairs of M. tuberculosis proteins (Rv1037c/Rv1038c, Rv1197/Rv1198, Rv1792/Rv1793, Rv2346c/Rv2347c, and Rv3619c/Rv3620c). There are no apparent M. leprae homologues for two pairs of
ESAT-6/CFP-10-related genes (Rv3890c/Rv3891c and Rv3904c/Rv3905c) and
one pair where there is an M. leprae equivalent for only one
(Rv3444c/Rv3445c). The M. leprae genome contains only 1,604 functional protein genes and has been proposed to represent the minimal
gene set for a pathogenic mycobacterium (9). The retention of both
ESAT-6 and CFP-10 as functional genes in M. leprae
reiterates clearly their importance in the lifestyle of mycobacterial
pathogens, and similar conservation arguments also suggest a
significant role for both Rv0287/Rv0288 and Rv3019c/Rv3020c. This is
supported by recent work (13), which showed that, like ESAT-6 and
CFP-10, the product of the Rv0287 gene is also secreted by M. tuberculosis cells in culture and is a major T-cell antigen
recognized by over 70% of tuberculosis patients.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 7.
Phylogenetic tree for the ESAT-6/CFP-10
family of M. tuberculosis proteins (prefixed by
Rv) and their M. leprae homologues
(prefixed by ML), with major pairing groups
highlighted by brackets and labeled. Bootstrap
values (%) are indicated for the major branch points in the tree. To
generate the family relationships shown in the tree, the protein
sequences were aligned initially and then bootstrapped 1,000 times
using the PAM 250 amino acid comparison table.
|
|
The other members of the ESAT-6/CFP-10 family of proteins are all found
as pairs in the genome of M. tuberculosis and are conserved
mainly as pairs in M. leprae, which suggests that these pairs of genes will also be regulated coordinately, and the paired protein products form tight, 1:1 complexes and function as
heterodimers. In addition, there is the interesting possibility that
complex formation between members of the ESAT-6/CFP-10 family of
proteins may not be limited to gene partners but could be much more
widespread, such that 22 sequences in M. tuberculosis could
give rise to many more than 11 functional protein complexes. This
clearly suggests a mechanism for enhanced functional flexibility of
ESAT-6/CFP-10 family proteins that may be very important for
pathogenesis and virulence of members of the M. tuberculosis
complex. Perhaps the best known precedence for this type of behavior is
the leucine zipper family of transcription factors (c-Jun, c-Fos,
cAMP-response element-binding protein (CREB), ATF1, ATF2, etc.), which
can form a large number of homo- and heterodimers with distinct
functional properties (33, 34). The characterization of the rules
governing complex formation between members of the ESAT-6/CFP-10
family, together with the determination of the solution structure of
the ESAT-6·CFP-10 complex, is the focus of ongoing work in our laboratory.
 |
FOOTNOTES |
*
This work was supported in part by Grants 047795 and 055394 from the Wellcome Trust, by the award of a Biotechnology and Biological Sciences Research Council studentship (to P. S. R.), and by the Veterinary Laboratories Agency, United Kingdom. M. C. is one of the
principle investigators of the M. tuberculosis Structural Genomics Consortium, which is supported by the National Institutes of
Health and by the United States Department of Energy.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.:
44-116-252-3054; Fax: 44-116-223-1503; E-mail: mdc12@le.ac.uk.
Published, JBC Papers in Press, April 8, 2002, DOI 10.1074/jbc.M201625200
 |
ABBREVIATIONS |
The abbreviations used are:
BCG, Bacille
Calmette-Guérin;
NMR, nuclear magnetic resonance;
Ni-NTA, nickel-nitrilotriacetic acid;
2D, two-dimensional.
 |
REFERENCES |
| 1.
|
Young, D. B.
(1998)
Nature
393,
515-516[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Stenger, S.,
and Modlin, R.
(1999)
Curr. Opin. Microbiol.
2,
89-93[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Elhers, S.
(1999)
FEMS Immunol. Med. Microbiol.
23,
149-158[Medline]
[Order article via Infotrieve]
|
| 4.
|
Zumla, A.,
and Grange, J.
(1998)
Br. Med. J.
316,
1962-1964[Free Full Text]
|
| 5.
|
Murray, C. J. L.,
and Salomon, J. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
13881-13886[Abstract/Free Full Text]
|
| 6.
|
Young, D. B.,
and Robertson, B. D.
(1999)
Science
284,
1479-1480[Free Full Text]
|
| 7.
|
Cole, S. T.,
Brosch, R.,
Parkhill, J.,
Garnier, T.,
Churcher, C.,
Harris, D.,
Gordon, S. V.,
Eiglmeier, K.,
Gas, S.,
Barry, C. E., III,
Tekaia, F.,
Badcock, K.,
Basham, D.,
Brown, D.,
Chillingworth, T.,
et al..
(1998)
Nature
393,
537-544[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Cole, S. T.
(1999)
FEBS Lett.
452,
7-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Cole, S. T.,
Eiglmeier, K.,
Parkhill, J.,
James, K. D.,
Thomson, N. R.,
Wheeler, P. R.,
Honore, N.,
Garnier, T.,
Churcher, C.,
Harris, D.,
Mungall, K.,
Basham, D.,
Brown, D.,
Chillingworth, T.,
Connor, R.,
et al..
(2001)
Nature
409,
1007-1011[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Mahairas, G. G.,
Sabo, P. J.,
Hickey, M. J.,
Sing, D. C.,
and Stover, C. K.
(1996)
J. Bacteriol.
178,
1274-1282[Abstract/Free Full Text]
|
| 11.
|
Behr, M. A.,
Wilson, M. A.,
Gill, W. P.,
Salamon, H.,
Schoolnik, G. K.,
Rane, S.,
and Small, P. M.
(1999)
Science.
284,
1520-1523[Abstract/Free Full Text]
|
| 12.
|
Berthet, F.-X.,
Ramussen, P. B.,
Rosenkrands, I.,
Andersen, P.,
and Gicquel, B.
(1998)
Microbiology
144,
3195-3203[Abstract/Free Full Text]
|
| 13.
|
Skjøt, R. L. V.,
Oettinger, T.,
Rosenkrands, I.,
Ravn, P.,
Brock, I.,
Jacobsen, S.,
and Andersen, P.
(2000)
Infect. Immun.
68,
214-220[Abstract/Free Full Text]
|
| 14.
|
van Pinxteren, L. A.,
Ravn, P.,
Agger, E. M.,
Pollock, J.,
and Andersen, P.
(2000)
Clin. Diagn. Lab. Immunol.
7,
155-160[Abstract/Free Full Text]
|
| 15.
|
Vordermeier, H. M.,
Whelan, A.,
Cockle, P. J.,
Farrant, L.,
Palmer, N.,
and Hewinson, R. G.
(2001)
Clin. Diagn. Lab. Immunol.
8,
571-578[Abstract/Free Full Text]
|
| 16.
|
Wards, B. J.,
de Lisle, G. W.,
and Collins, D. M.
(2000)
Tuber. Lung Dis.
80,
185-189[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Tekaia, F.,
Gordon, S. V.,
Garnler, T.,
Brosch, R.,
Barrell, B. G.,
and Cole, S. T.
(1999)
Tuber. Lung Dis.
79,
329-342[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Brosch, R.,
Gordon, S. V.,
Billault, A.,
Garnier, T.,
Eiglmeier, K.,
Soravito, C.,
Barrell, B. G.,
and Cole, S. T.
(1998)
Infect. Immun.
66,
2221-2229[Abstract/Free Full Text]
|
| 19.
|
Macura, S.,
and Ernst, R. R.
(1980)
Mol. Phys.
41,
95-117[CrossRef]
|
| 20.
|
Braunschweiler, L.,
and Ernst, R. R.
(1983)
J. Magn. Reson.
53,
521-528
|
| 21.
|
Williamson, R. A.,
Natalia, D.,
Gee, C. K.,
Murphy, G.,
Carr, M. D.,
and Freedman, R. B.
(1996)
Eur. J. Biochem.
241,
476-483[Medline]
[Order article via Infotrieve]
|
| 22.
|
Thompson, J. D.,
Gibson, T. J.,
Plewniak, F.,
Jeanmougin, F.,
and Higgins, D. G.
(1997)
Nucleic Acids Res.
25,
4876-4882[Abstract/Free Full Text]
|
| 23.
|
Sreerama, N.,
and Woody, R. W.
(1993)
Anal. Biochem.
209,
32-44[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Sreerama, N.,
Venyaminov, S. Y.,
and Woody, R. W.
(1999)
Protein Sci.
8,
370-380[Medline]
[Order article via Infotrieve]
|
| 25.
|
Sreerama, N.,
and Woody, R. W.
(2000)
Anal. Biochem.
287,
252-260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Wüthrich, K.
(1986)
NMR of Proteins and Nucleic Acids
, John Wiley & Sons, Inc., New York.
|
| 27.
|
Feeney, J.,
Bauer, C. J.,
Frenkiel, T. A.,
Birdsall, B.,
Carr, M. D.,
Roberts, G. C. K.,
and Arnold, J. R. P.
(1991)
J. Magn. Reson.
91,
607-613
|
| 28.
|
Cuff, J. A.,
Clamp, M.,
Siddiqui, A. S.,
Finlay, M.,
and Barton, G. J.
(1998)
Bioinformatics
14,
892-893[Abstract/Free Full Text]
|
| 29.
|
Sorensen, A. L.,
Nagai, S.,
Houen, G.,
Andersen, P.,
and Andersen, A. B.
(1995)
Infect. Immun.
63,
1710-1717[Abstract]
|
| 30.
|
Carr, M. D.,
Wollborn, U.,
McIntosh, P. B.,
Frenkiel, T. A.,
McCormick, J. E.,
Bauer, C. J.,
Klempnauer, K.-H.,
and Feeney, J.
(1996)
Eur. J. Biochem.
235,
721-735[Medline]
[Order article via Infotrieve]
|
| 31.
|
Wright, P. E.,
and Dyson, H. J.
(1999)
J. Mol. Biol.
293,
321-331[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Gey van Pittius, N. C.,
Gamieldien, J.,
Hide, W.,
Brown, G. D.,
Siezen, R. J.,
and Beyers, A. D.
(2001)
Genome Biol.
2,
1-18
|
| 33.
|
Glover, J. N. M.,
and Harrison, S. C.
(1995)
Nature
373,
257-261[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Kerppola, T.,
and Curran, T.
(1995)
Nature
373,
199-200[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Wang, P. F. Barnes, K. M. Dobos-Elder, J. C. Townsend, Y.-t. Chung, H. Shams, S. E. Weis, and B. Samten
ESAT-6 Inhibits Production of IFN-{gamma} by Mycobacterium tuberculosis-Responsive Human T Cells
J. Immunol.,
March 15, 2009;
182(6):
3668 - 3677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Luthra, A. Mahmood, A. Arora, and R. Ramachandran
Characterization of Rv3868, an Essential Hypothetical Protein of the ESX-1 Secretion System in Mycobacterium tuberculosis
J. Biol. Chem.,
December 26, 2008;
283(52):
36532 - 36541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Smith, J. Manoranjan, M. Pan, A. Bohsali, J. Xu, J. Liu, K. L. McDonald, A. Szyk, N. LaRonde-LeBlanc, and L.-Y. Gao
Evidence for Pore Formation in Host Cell Membranes by ESX-1-Secreted ESAT-6 and Its Role in Mycobacterium marinum Escape from the Vacuole
Infect. Immun.,
December 1, 2008;
76(12):
5478 - 5487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A-R. Shin, S. J. Shin, K.-S. Lee, S.-H. Eom, S.-S. Lee, B.-S. Lee, J.-S. Lee, S. N. Cho, and H.-J. Kim
Improved Sensitivity of Diagnosis of Tuberculosis in Patients in Korea via a Cocktail Enzyme-Linked Immunosorbent Assay Containing the Abundantly Expressed Antigens of the K Strain of Mycobacterium tuberculosis
Clin. Vaccine Immunol.,
December 1, 2008;
15(12):
1788 - 1795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Garufi, E. Butler, and D. Missiakas
ESAT-6-Like Protein Secretion in Bacillus anthracis
J. Bacteriol.,
November 1, 2008;
190(21):
7004 - 7011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. P. Harrington, O. P. Surujballi, J. F. Prescott, J. R. Duncan, W. R. Waters, K. Lyashchenko, and R. Greenwald
Antibody Responses of Cervids (Cervus elaphus) following Experimental Mycobacterium bovis Infection and the Implications for Immunodiagnosis
Clin. Vaccine Immunol.,
November 1, 2008;
15(11):
1650 - 1658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Woodworth, S. M. Fortune, and S. M. Behar
Bacterial Protein Secretion Is Required for Priming of CD8+ T Cells Specific for the Mycobacterium tuberculosis Antigen CFP10
Infect. Immun.,
September 1, 2008;
76(9):
4199 - 4205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Lightbody, D. Ilghari, L. C. Waters, G. Carey, M. A. Bailey, R. A. Williamson, P. S. Renshaw, and M. D. Carr
Molecular Features Governing the Stability and Specificity of Functional Complex Formation by Mycobacterium tuberculosis CFP-10/ESAT-6 Family Proteins
J. Biol. Chem.,
June 20, 2008;
283(25):
17681 - 17690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kobashi, K. Mouri, S. Yagi, Y. Obase, N. Miyashita, N. Okimoto, T. Matsushima, T. Kageoka, and M. Oka
Clinical Utility of the QuantiFERON TB-2G Test for Elderly Patients With Active Tuberculosis
Chest,
May 1, 2008;
133(5):
1196 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ventura, C. Canchaya, A. Tauch, G. Chandra, G. F. Fitzgerald, K. F. Chater, and D. van Sinderen
Genomics of Actinobacteria: Tracing the Evolutionary History of an Ancient Phylum
Microbiol. Mol. Biol. Rev.,
September 1, 2007;
71(3):
495 - 548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. de Jonge, G. Pehau-Arnaudet, M. M. Fretz, F. Romain, D. Bottai, P. Brodin, N. Honore, G. Marchal, W. Jiskoot, P. England, et al.
ESAT-6 from Mycobacterium tuberculosis Dissociates from Its Putative Chaperone CFP-10 under Acidic Conditions and Exhibits Membrane-Lysing Activity
J. Bacteriol.,
August 15, 2007;
189(16):
6028 - 6034.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. MacGurn and J. S. Cox
A Genetic Screen for Mycobacterium tuberculosis Mutants Defective for Phagosome Maturation Arrest Identifies Components of the ESX-1 Secretion System
Infect. Immun.,
June 1, 2007;
75(6):
2668 - 2678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. B. E. Chee, K. W. KhinMar, S. H. Gan, T. M. S. Barkham, M. Pushparani, and Y. T. Wang
Latent Tuberculosis Infection Treatment and T-Cell Responses to Mycobacterium tuberculosis-specific Antigens
Am. J. Respir. Crit. Care Med.,
February 1, 2007;
175(3):
282 - 287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. A. D. Champion, S. A. Stanley, M. M. Champion, E. J. Brown, and J. S. Cox
C-terminal signal sequence promotes virulence factor secretion in Mycobacterium tuberculosis.
Science,
September 15, 2006;
313(5793):
1632 - 1636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Singh, D. Mai, A. Kumar, and A. J. C. Steyn
Dissecting virulence pathways of Mycobacterium tuberculosis through protein-protein association
PNAS,
July 25, 2006;
103(30):
11346 - 11351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strong, M. R. Sawaya, S. Wang, M. Phillips, D. Cascio, and D. Eisenberg
Toward the structural genomics of complexes: Crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis
PNAS,
May 23, 2006;
103(21):
8060 - 8065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chen, H. Gan, and H. G. Remold
A Mechanism of Virulence: Virulent Mycobacterium tuberculosis Strain H37Rv, but Not Attenuated H37Ra, Causes Significant Mitochondrial Inner Membrane Disruption in Macrophages Leading to Necrosis
J. Immunol.,
March 15, 2006;
176(6):
3707 - 3716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. V. Palmer, W. R. Waters, T. C. Thacker, R. Greenwald, J. Esfandiari, and K. P. Lyashchenko
Effects of Different Tuberculin Skin-Testing Regimens on Gamma Interferon and Antibody Responses in Cattle Experimentally Infected with Mycobacterium bovis.
Clin. Vaccine Immunol.,
March 1, 2006;
13(3):
387 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Waters, M. V. Palmer, R. E. Slaughter, S. L. Jones, J. E. Pitzer, and F. C. Minion
Diagnostic Implications of Antigen-Induced Gamma Interferon Production by Blood Leukocytes from Mycobacterium bovis-Infected Reindeer (Rangifer tarandus)
Clin. Vaccine Immunol.,
January 1, 2006;
13(1):
37 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Marei, A. Ghaemmaghami, P. Renshaw, M. Wiselka, M. Barer, M. Carr, and L. Ziegler-Heitbrock
Superior T cell activation by ESAT-6 as compared with the ESAT-6-CFP-10 complex
Int. Immunol.,
November 1, 2005;
17(11):
1439 - 1446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Brodin, M. I. de Jonge, L. Majlessi, C. Leclerc, M. Nilges, S. T. Cole, and R. Brosch
Functional Analysis of Early Secreted Antigenic Target-6, the Dominant T-cell Antigen of Mycobacterium tuberculosis, Reveals Key Residues Involved in Secretion, Complex Formation, Virulence, and Immunogenicity
J. Biol. Chem.,
October 7, 2005;
280(40):
33953 - 33959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Maue, W. R. Waters, W. C. Davis, M. V. Palmer, F. C. Minion, and D. M. Estes
Analysis of Immune Responses Directed toward a Recombinant Early Secretory Antigenic Target Six-Kilodalton Protein-Culture Filtrate Protein 10 Fusion Protein in Mycobacterium bovis-Infected Cattle
Infect. Immun.,
October 1, 2005;
73(10):
6659 - 6667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Fortune, A. Jaeger, D. A. Sarracino, M. R. Chase, C. M. Sassetti, D. R. Sherman, B. R. Bloom, and E. J. Rubin
Mutually dependent secretion of proteins required for mycobacterial virulence
PNAS,
July 26, 2005;
102(30):
10676 - 10681.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Sable, I. Verma, D. Behera, and G. K. Khuller
Human immune recognition-based multicomponent subunit vaccines against tuberculosis
Eur. Respir. J.,
May 1, 2005;
25(5):
902 - 910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Hill, D. Jackson-Sillah, A. Fox, K. L. M. C. Franken, M. D. Lugos, D. J. Jeffries, S. A. Donkor, A. S. Hammond, R. A. Adegbola, T. H. M. Ottenhoff, et al.
ESAT-6/CFP-10 Fusion Protein and Peptides for Optimal Diagnosis of Mycobacterium tuberculosis Infection by Ex Vivo Enzyme-Linked Immunospot Assay in The Gambia
J. Clin. Microbiol.,
May 1, 2005;
43(5):
2070 - 2074.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Collins, B. Skou, S. White, S. Bassett, L. Collins, R. For, K. Hurr, G. Hotter, and G. W. de Lisle
Generation of Attenuated Mycobacterium bovis Strains by Signature-Tagged Mutagenesis for Discovery of Novel Vaccine Candidates
Infect. Immun.,
April 1, 2005;
73(4):
2379 - 2386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Converse and J. S. Cox
A Protein Secretion Pathway Critical for Mycobacterium tuberculosis Virulence Is Conserved and Functional in Mycobacterium smegmatis
J. Bacteriol.,
February 15, 2005;
187(4):
1238 - 1245.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Burts, W. A. Williams, K. DeBord, and D. M. Missiakas
EsxA and EsxB are secreted by an ESAT-6-like system that is required for the pathogenesis of Staphylococcus aureus infections
PNAS,
January 25, 2005;
102(4):
1169 - 1174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Kamath, J. Woodworth, X. Xiong, C. Taylor, Y. Weng, and S. M. Behar
Cytolytic CD8+ T Cells Recognizing CFP10 Are Recruited to the Lung after Mycobacterium tuberculosis Infection
J. Exp. Med.,
December 6, 2004;
200(11):
1479 - 1489.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Shams, P. Klucar, S. E. Weis, A. Lalvani, P. K. Moonan, H. Safi, B. Wizel, K. Ewer, G. T. Nepom, D. M. Lewinsohn, et al.
Characterization of a Mycobacterium tuberculosis Peptide That Is Recognized by Human CD4+ and CD8+ T Cells in the Context of Multiple HLA Alleles
J. Immunol.,
August 1, 2004;
173(3):
1966 - 1977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Waters, B. J. Nonnecke, M. V. Palmer, S. Robbe-Austermann, J. P. Bannantine, J. R. Stabel, D. L. Whipple, J. B. Payeur, D. M. Estes, J. E. Pitzer, et al.
Use of Recombinant ESAT-6:CFP-10 Fusion Protein for Differentiation of Infections of Cattle by Mycobacterium bovis and by M. avium subsp. avium and M. avium subsp. paratuberculosis
Clin. Vaccine Immunol.,
July 1, 2004;
11(4):
729 - 735.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. C. Frota, D. M. Hunt, R. S. Buxton, L. Rickman, J. Hinds, K. Kremer, D. van Soolingen, and M. J. Colston
Genome structure in the vole bacillus, Mycobacterium microti, a member of the Mycobacterium tuberculosis complex with a low virulence for humans
Microbiology,
May 1, 2004;
150(5):
1519 - 1527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Okkels and P. Andersen
Protein-Protein Interactions of Proteins from the ESAT-6 Family of Mycobacterium tuberculosis
J. Bacteriol.,
April 15, 2004;
186(8):
2487 - 2491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Shi, R. North, and M. L. Gennaro
Effect of Growth State on Transcription Levels of Genes Encoding Major Secreted Antigens of Mycobacterium tuberculosis in the Mouse Lung
Infect. Immun.,
April 1, 2004;
72(4):
2420 - 2424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Okkels, I. Brock, F. Follmann, E. M. Agger, S. M. Arend, T. H. M. Ottenhoff, F. Oftung, I. Rosenkrands, and P. Andersen
PPE Protein (Rv3873) from DNA Segment RD1 of Mycobacterium tuberculosis: Strong Recognition of Both Specific T-Cell Epitopes and Epitopes Conserved within the PPE Family
Infect. Immun.,
November 1, 2003;
71(11):
6116 - 6123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Carr, M. J. Bloemink, E. Dentten, A. O. Whelan, S. V. Gordon, G. Kelly, T. A. Frenkiel, R. G. Hewinson, and R. A. Williamson
Solution Structure of the Mycobacterium tuberculosis Complex Protein MPB70: FROM TUBERCULOSIS PATHOGENESIS TO INHERITED HUMAN CORNEAL DISEASE
J. Biol. Chem.,
October 31, 2003;
278(44):
43736 - 43743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Stanley, S. Raghavan, W. W. Hwang, and J. S. Cox
Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system
PNAS,
October 28, 2003;
100(22):
13001 - 13006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hsu, S. M. Hingley-Wilson, B. Chen, M. Chen, A. Z. Dai, P. M. Morin, C. B. Marks, J. Padiyar, C. Goulding, M. Gingery, et al.
The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue
PNAS,
October 14, 2003;
100(21):
12420 - 12425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Aagaard, M. Govaerts, L. Meng Okkels, P. Andersen, and J. M. Pollock
Genomic Approach to Identification of Mycobacterium bovis Diagnostic Antigens in Cattle
J. Clin. Microbiol.,
August 1, 2003;
41(8):
3719 - 3728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Smith
Mycobacterium tuberculosis Pathogenesis and Molecular Determinants of Virulence
Clin. Microbiol. Rev.,
July 1, 2003;
16(3):
463 - 496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Garnier, K. Eiglmeier, J.-C. Camus, N. Medina, H. Mansoor, M. Pryor, S. Duthoy, S. Grondin, C. Lacroix, C. Monsempe, et al.
The complete genome sequence of Mycobacterium bovis
PNAS,
June 24, 2003;
100(13):
7877 - 7882.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Goyal, L. Tisi, A. Basran, J. Browne, A. Burnell, J. Zurdo, and A. Tunnacliffe
Transition from Natively Unfolded to Folded State Induced by Desiccation in an Anhydrobiotic Nematode Protein
J. Biol. Chem.,
April 4, 2003;
278(15):
12977 - 12984.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|